Understanding the Impact of Diabetes on Vision
Diabetes can have a significant impact on eye health, leading to conditions like retinopathy, glaucoma, cataract, and changes in refractive errors. Nearly 5% of Australians have diabetes, with a high risk of developing related eye problems. Recognizing early signs such as blurred or fluctuating visi
0 views • 15 slides
Managing Diabetes in Pregnancy: Preconception and Post-conception Care
Providing preconception care for women with established type 1 or type 2 diabetes is crucial for ensuring a healthy pregnancy. This involves counseling on effective contraception, evaluating and treating diabetes-related complications, reviewing risks of uncontrolled diabetes during pregnancy, and d
0 views • 37 slides
Comprehensive Overview of Diabetic Retinopathy Screening Study
This comprehensive report delves into the key performance indicators, reports, populations, dates, and screening outcomes of the Diabetic Retinopathy Screening Study conducted on November 4th, 2008. It covers aspects such as screening uptake, performance, ophthalmology care, successful and unsuccess
0 views • 11 slides
Insights into Paediatric Ophthalmology: Common Conditions and Trachoma Treatment Strategies
Explore the world of paediatric ophthalmology through a detailed discussion on common eye conditions needing co-management, such as congenital anomalies and retinopathy, as well as the debilitating effects of trachoma caused by Chlamydia infection. Trachoma can lead to blindness if left untreated, e
2 views • 27 slides
Enhancing Diabetes Retinopathy Screening Awareness Among Young People in Scotland
This presentation explores young people's perceptions of diabetes retinopathy screening in Scotland, highlighting disparities between invitation rates and attendance across different age groups. The proposal aims to raise awareness through DUKIT initiatives such as surveys and information leaflets t
0 views • 4 slides
Long-Term Effects of Ranibizumab Treatment on Diabetic Retinopathy Severity: DRCR.net Protocol I 5-Year Report
Phase 3 trials have demonstrated favorable changes in diabetic retinopathy severity in eyes treated with ranibizumab for diabetic macular edema. This study focuses on the 5-year outcomes of ranibizumab therapy in managing diabetic retinopathy progression, especially with decreasing exposure to anti-
0 views • 24 slides